In comparison with BRCA1 or BRCA2 cancers, familial non-BRCA1/2 cancers represented a much greater number of ER-positive and PgR-positive cases; however, in comparison with the unselected control group they were more receptor-negative. Here, BRCA2 is linked to cancer.